Remove Doctors Remove Food Remove Patients Remove Side effects
article thumbnail

Are new weight loss drugs an answer or problem?

World of DTC Marketing

Unpaid celebrity endorsements include venture capitalist Marc Andreessen, who says the drug completely changed his relationship with food, and Elon Musk, who has cited it on Twitter. But before the company can make Wegovy mainstream, it has to convince doctors to prescribe it and insurers and governments to pay for it.

article thumbnail

Getting an Rx does not address health problems

World of DTC Marketing

Pharma websites provide the prescription that can help people overcome health problems but too often, they ignore the patient’s responsibility to lose weight and exercise. While the population is more worried about COVID, they are killing themselves by overeating processed food and not getting any exercise.

Insurance 200
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A scientific approach to irrational consumer choices

World of DTC Marketing

” So, are we supposed to believe that better images in DTC ads lead to patients asking for an Rx? Virtually nobody will run to their doctor to ask about a drug they saw on TV without doing research first. What people seem to be interested in are drug side effects vs. efficacy. ” Uh…no.

article thumbnail

It’s been a long time coming for long-term topical psoriasis treatments

pharmaphorum

Psoriasis is a tricky disease to manage, as drawbacks and side effects loom with each and every type of treatment. But two new non-steroidal topicals were introduced this year — Dermavant Science’s Vtama and Arcutis Biotherapeutics’ Zoryve — and each one solves a long-time problem plaguing millions of psoriasis patients.

article thumbnail

How Pharmacogenomics may finally realise its promise

pharmaphorum

The system did not only spend money and resources trying to address issues caused by those treatments, but patients also wasted time looking for answers; precious time that could have been spent receiving proper and effective treatment. billion in the United States alone.

article thumbnail

FDA makes moves to advance ALS research ahead of upcoming Amylyx AdCom

Pharmaceutical Technology

In the lead-up to a critical meeting that will influence the approval of a new drug for amyotrophic lateral sclerosis (ALS), the US Food and Drug Administration (FDA) has detailed its plans to advance rare neurodegenerative disease research. The other therapy Mitsubishi Tanabe Pharma’s Radicava is only effective in the early stages of ALS.

FDA 98
article thumbnail

Surviving Cancer And Making An Impact To Cancer Patients’ Lives With Rob Ciaramitaro

Evolve Your Success

— Watch the episode here Listen to the podcast here Surviving Cancer And Making An Impact To Cancer Patients’ Lives With Rob Ciaramitaro In this episode, we have with us another special guest and he goes by the name of Rob Ciaramitaro. Is it doctors, more hospital staff, or clinic founders? Diagnostic sales is the difference.